Bookbot

The Pharmagellan Guide to Biotech Forecasting and Valuation

Parameters

More about the book

If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.

Book purchase

The Pharmagellan Guide to Biotech Forecasting and Valuation, Andrew Matthews, Frank S. David, Seth Robey

Language
Released
2017
product-detail.submit-box.info.binding
(Paperback)
We’ll notify you via email once we track it down.

Payment methods